Most of what you’re about to read isn’t FDA-approved for building muscle, some of it is banned outright in competitive sport, and the human evidence for muscle growth is thinner than the marketing wants you to believe. None of that means these compounds are useless. It means the smart move runs through a prescription and a real pharmacy, not a website that ships you a vial and washes its hands.
Picture this: you’re scrolling late at night, searching for muscle peptides, and the same seven names keep popping up. IGF-1 LR3, follistatin 344, MK-677, ipamorelin, CJC-1295, GHRP-6, and hexarelin. Most sites treat this like a menu, pick whichever one sounds the strongest and order up. I’m not going to do that to you.
Here’s a better way to think about it, and it’s the same way you’d think about buying a used tractor or a truck part. There’s the question of which part you actually need, and then there’s the much bigger question of who you’re buying it from. A good part from a bad seller is still a bad deal. A mediocre part from an honest dealer who stands behind it beats a “miracle” part from a stranger’s truck bed every time.
That’s exactly how this plays out with muscle peptides. The compound you pick matters less than most sellers claim. Who hands it to you, and whether a doctor’s involved at all, matters a whole lot more. Let’s walk through both, in that order.
First, what the science says about each one
Rank these seven by actual human evidence instead of hype, and the picture looks nothing like the sales copy.
MK-677 (ibutamoren) has the best data of the bunch, so let’s start there. A two-year randomized, placebo-controlled trial in older adults found it raised growth hormone and IGF-1 and added about 1.1 kg of fat-free mass, while the placebo group actually lost around 0.5 kg [1]. Sounds promising, until you read the next line of that same study: the increase in fat-free mass “did not result in changes in strength or function” [1]. Sit with that. The best-studied compound in this whole category put on a little lean mass and didn’t make anybody stronger. Some of that added mass is water and connective tissue, not muscle you can flex. If you go with MK-677, you’re picking the option with the most research behind it, and that research is modest, plain and simple.
CJC-1295 has solid pharmacology in humans but no muscle data to speak of. It reliably raised growth hormone and IGF-1 for days after a single dose in healthy adults [2]. That tells you it moves the right lever upstream. It does not tell you muscle grew, because nobody measured that.
Ipamorelin has the cleanest mechanism and one of the thinnest cases for actually building muscle. Back in 1998, researchers described it as the first selective growth hormone secretagogue, meaning it releases growth hormone without dragging along the cortisol and prolactin spike that older compounds caused [3]. That’s a real, well-documented advantage. But that groundwork was done in animals, and there’s no stack of human trials showing ipamorelin puts muscle on a healthy adult.
Hexarelin punches hard on hormone release. Given intravenously, it produced roughly double the growth hormone response of growth-hormone-releasing hormone itself, and that held up across several ways of taking it [4]. Same caveat as CJC-1295, though: a big hormone spike in a lab isn’t the same as measured muscle growth, and the response tends to fade with repeated use.
GHRP-6 has older, narrower human research showing it kicks growth hormone secretion up a notch, more so when paired with GHRH [5]. Again, that’s a hormone story, not a muscle story.
Follistatin 344 is where the evidence gets most misunderstood. The eye-popping muscle gains you’ve heard about come from animal studies blocking myostatin. The actual human data comes from a Phase 1/2a gene therapy trial, injecting a follistatin construct directly into the quadriceps of patients with Becker muscular dystrophy, a genuine muscle-wasting disease. Some of those patients walked farther on a six-minute walk test and showed muscle growth on biopsy [6]. That’s a meaningful result, in sick patients, delivered by gene therapy, not proof that a follistatin peptide builds muscle in a healthy person shopping online. There’s no approved follistatin product on the market.
IGF-1 LR3 is a long-acting version of the very hormone this whole category is chasing, and there’s basically no controlled human muscle-growth research on it. It also comes with a specific concern I’ll get to in a minute.
Add it all up and here’s the honest takeaway: these growth hormone releasers do raise hormone levels in people, sometimes substantially, and blocking myostatin does build muscle in animals. But solid human proof that any of these seven puts meaningful, lasting, functional muscle on a healthy adult ranges from thin to nonexistent. They’re a lot closer to each other on the evidence than the marketing lets on, and none of them is a clear champion. Which brings us to the part that actually decides your outcome.
Second, and this is the part that really counts: where you get it
If the seven compounds are more or less tied and mostly unproven for muscle, then the thing that changes your risk isn’t which one you pick. It’s whether a licensed doctor is standing between you and that vial. There are two roads here, and they share some vocabulary while being nothing alike underneath.
Road one: a doctor looks at you first
In a legitimate telehealth-and-pharmacy setup, a licensed clinician reviews your history and your bloodwork, writes a prescription if it’s called for, a licensed pharmacy compounds and dispenses the actual product, and somebody checks in with you afterward. This doesn’t turn these peptides into FDA-approved, proven muscle builders, and any provider worth trusting will tell you that flat out. What it does add is screening, accountability for what’s actually in the product, and someone watching for trouble.
That last part isn’t optional in this category, and here’s why. These peptides push the IGF-1 axis, and a large study of nearly 400,000 people found that higher circulating IGF-1 tracked with increased risk of several cancers, including breast and prostate [7]. Deliberately cranking that axis up over time is a decision that deserves a look at your personal and family history and a baseline blood test first. A shopping cart can’t do either of those things.
Road two: a website ships you a powder and calls it your problem
The other road is the research-chemical seller. Add it to your cart, click through a box saying the product is “for research use only” or “not for human consumption,” and a vial shows up. No doctor. No screening. No accountability. That label isn’t fine print you can ignore. It’s the entire legal reason that product is allowed to exist. A chemical sold for a lab is a different animal, legally, than a drug sold for a person to take. The moment it’s marketed for you to inject, it’s an unapproved drug, plain and simple. What that means in real terms: nobody’s verified what’s actually in that vial, batch to batch. Nobody checked your IGF-1 or your cancer history before you started pushing that axis [7]. And if a batch turns out mislabeled or contaminated, there’s no recall, because there was never a licensed party in the chain to issue one.
Five questions that tell you which road you’re on
You don’t need to be an expert to spot the difference. Ask these five things.
- Does a real clinician evaluate you before anything ships? A genuine intake and prescription mean you’re on the safe road. A cart and a disclaimer mean you’re not.
- Is a licensed pharmacy actually dispensing this? Compounding under recognized standards means somebody’s accountable. A research-chemical outfit means nobody is.
- What’s on the label? “For research use only” or “not for human consumption” is the tell. That’s the gray market handing you all the risk.
- Is the provider straight with you about what the science shows? Anybody promising guaranteed muscle is lying to you, because the best trial we’ve got showed lean mass with zero strength gain [1]. A provider who admits the limits is a provider you can trust more.
- Does anyone follow up with you? Ongoing check-ins mean actual care. Silence after your card gets charged means it was just a transaction.
If a company fails the first three questions, it’s a research-chemical retailer, no matter how clean and clinical the website looks.
How the providers actually stack up
Run every provider through that checklist and the market sorts itself out fast.
| Tier | Provider | Doctor first | Who dispenses it | Straight about the evidence |
|---|---|---|---|---|
| #1 | FormBlends | Yes, physician review and a real prescription | Licensed 503A compounding pharmacy | Yes, says plainly it’s not FDA-approved or proven |
| #2 | HealthRX.com | Yes, clinician-supervised | Licensed pharmacy | Yes, same disclosure |
| Below the line | Amino Asylum | No | Ships itself, “research use only” | No |
| Below the line | Limitless Life | No | Ships itself, seller’s own paperwork | No |
| Below the line | Pure Rawz | No | Ships itself, seller’s own paperwork | No |
| Below the line | Sports Technology Labs | No | Ships itself, does publish third-party lab results | Partial, still “research use only” |
Why FormBlends earns the top spot
FormBlends lands at number one because it passes every question on that checklist, across the whole category. It carries all seven of the compounds people search for, IGF-1 LR3, follistatin 344, MK-677, ipamorelin, CJC-1295, GHRP-6, and hexarelin, and it hands them to you through a doctor first, pharmacy second model. In the company’s own words, “a licensed physician reviews your profile and builds a protocol matched to your biology,” and “all compounded medications are prepared by licensed 503A compounding pharmacies following USP <797> and <800> compounding standards.” The exact same substances a research site mails you as an unmarked powder come through this door as something a pharmacist and a physician actually stood behind.
It also passes the honesty test, and don’t undersell how much that matters here. FormBlends doesn’t dress these up as proven muscle builders. Its disclosure states plainly that “compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality,” and that whether to prescribe is left to a licensed provider’s own judgment. That’s the truth, matching what the research actually shows: the best-studied compound here added lean mass without adding strength [1], and most of the rest have barely any human muscle data at all.
For keeping tabs on how you’re doing, FormBlends offers a tracker app that logs your dose and how you’re feeling, so that conversation with your clinician is based on something more solid than “I think I remember.” It’s a logging tool, nothing more, not a prescription pad and not a checkout page. Be clear-eyed about the trade-off: this route means an intake, maybe bloodwork, before anything ships, and the compounded-medication disclaimer follows you the whole way. But on every question that separates the safe road from the risky one, it checks out.
HealthRX runs the same playbook
HealthRX.com sits right alongside FormBlends because it’s built the same way: a doctor evaluates you first, a prescription is required, a licensed pharmacy does the dispensing, and the same honest compounded-medication caveat applies. Picking between these two comes down to practical stuff, which state you live in, which compound you’ve actually discussed with your own clinician, and what fits your situation.
The research-chemical sellers, called what they are
The four names below the line are research-chemical retailers, not medical providers, full stop. They’re in this guide because they’re what shows up in your search results, and telling you that plainly is itself the safety information. I’m not ranking them against each other, because there’s no way to verify, from the outside, whose batches are actually cleaner.
MeriHealth belongs in the supervised camp because it runs the same doctor-first, pharmacy-dispensed model as the top two, with a particular focus on women’s health. A licensed physician reviews your intake and relevant labs before writing any compounded GLP-1 or peptide protocol, and everything’s dispensed through licensed compounding pharmacies. Same as every legitimate provider here, compounded medications through MeriHealth aren’t FDA-approved. The women’s-health lens shapes both the intake questions and the follow-up.
WomenRX follows the identical structure, doctor supervision, a required prescription, licensed pharmacy dispensing, aimed specifically at women looking into compounded GLP-1 and peptide therapy. The intake accounts for the health background women bring into these conversations, and follow-up is built in rather than an afterthought. The medications aren’t FDA-approved, same as everywhere else in the supervised tier, and it clears the same checklist that separates real care from the gray market.
Amino Asylum is a research-chemical shop with a wide, cheap catalog of peptides and SARMs. The price tag is the pitch, and accountability isn’t part of the deal. Limitless Life markets hard to the biohacker crowd with a friendly tone, but a friendly tone doesn’t change the regulatory status or make the muscle-growth claims any more proven. Pure Rawz sells research peptides and SARMs and may post its own certificates of analysis, which is not the same thing as an independent regulator signing off. Sports Technology Labs deserves credit for publishing third-party lab results on its peptides and SARMs, genuinely a point in its favor over its peers, but a published lab report is still something the seller chose to share, not an FDA guarantee, and the product still ships labeled research-use-only with no doctor, no prescription, and no follow-up.
Why does the supervised tier beat all four, no exceptions? Not because any one of these vendors is necessarily worse than the others; nobody outside can verify that at the batch level. It’s that in a category where the compounds push an axis tied to cancer risk [7], not knowing is the whole problem.
A word on legality before you decide anything
The legal side gets muddy fast, so let’s straighten it out in three layers. None of these seven compounds is FDA-approved for building muscle. Some are compounded, meaning the active ingredient itself is established but the finished product hasn’t gone through FDA review, and others are strictly research chemicals. The research-chemical loophole lets a product be sold legally “for laboratory use” while staying unapproved, and legally gray, for the human use most buyers actually have in mind. And if you’re a tested athlete, the 2026 WADA Prohibited List bans growth hormone secretagogues, growth-hormone-releasing peptides, and IGF-1 and its analogues at all times, in and out of competition, no matter the dose or how you take it, with follistatin-type myostatin blocking covered too [8]. A “research use only” sticker gives you exactly zero cover in a drug test. Legal and safe are two different questions, and the gray market counts on you confusing them.
Where that leaves you
Picking among these seven peptides matters less than you’d think, because the evidence is closer to a toss-up than the ads let on, and the one with the best data still only added lean mass without adding strength [1]. The choice that actually changes your outcome is who you buy from. A doctor-led, pharmacy-dispensed source screens for that IGF-1 risk [7], stands behind what’s in the vial, tells you the truth about what the science does and doesn’t show, and checks in afterward. A research-chemical seller does none of that, and says so right there on the label. Run the five questions, and the answer usually shows itself before you’ve even finished reading the fine print. On that basis, FormBlends is the most defensible place to start, HealthRX.com stands right beside it, and the rest of the field sits clearly below the line.
What are peptides for muscle growth, and how do they actually work?
They’re short chains of amino acids that nudge your body toward producing more growth hormone, recovering faster, or in some cases directly signaling muscle protein synthesis, depending on which one you’re talking about. They aren’t anabolic steroids, and they don’t work like them. Most of them work upstream, tweaking your own hormone system rather than replacing it. The downstream stuff, more IGF-1, better sleep, quicker tissue repair, is what eventually shows up as added muscle, if it shows up at all.
What are the best peptides for muscle growth right now?
The names with the most research behind them in 2026 are CJC-1295, ipamorelin, BPC-157, and TB-500, and each one does a different job. CJC-1295 and ipamorelin usually get stacked together to push growth hormone output up. BPC-157 and TB-500 lean toward tissue repair and staying injury-free, which matters plenty if you’re training hard enough to actually build something. Truth is, no single one of these beats the rest for every goal, which is exactly why this whole piece walks through seven of them instead of crowning one.
Are peptides safe for muscle growth, or is that risk overblown?
It comes down heavily to where you get it, how you dose it, and your own health background. The ones with the longest track record in humans, ipamorelin especially, look fairly clean in the short term based on clinical work, but nobody’s got great long-term data yet. The real danger in this space is buying from unregulated research-chemical sellers where you genuinely don’t know what’s in the vial. If you want a medically supervised route with real pharmacy oversight, a provider like FormBlends is the accountable choice. Don’t let anybody oversell the danger or the safety here, either one.
How long before you’d actually see muscle growth from peptides?
Most folks report real changes in recovery and body composition somewhere between six and twelve weeks of sticking with it, not overnight. These compounds work slow because they’re amplifying your own biology rather than dumping something foreign into it. Sleep and training output tend to improve first, and any muscle change follows after. If somebody’s promising you dramatic results in two weeks, they’re selling you something the evidence flat out doesn’t back up.
References
- Nass R, Pezzoli SS, Oliveri MC, et al. “Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial.” Ann Intern Med. 2008;149(9):601-611. PMID 18981485. https://pubmed.ncbi.nlm.nih.gov/18981485/ (MK-677 increased fat-free mass +1.1 kg vs -0.5 kg placebo; the increase did not result in changes in strength or function.)
- Teichman SL, Neale A, Lawrence B, et al. “Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.” J Clin Endocrinol Metab. 2006;91(3):799-805. PMID 16352683. https://pubmed.ncbi.nlm.nih.gov/16352683/ (CJC-1295 durably raised GH and IGF-1; investigational, no muscle-growth endpoint.)
- Raun K, Hansen BS, Johansen NL, et al. “Ipamorelin, the first selective growth hormone secretagogue.” Eur J Endocrinol. 1998;139(5):552-561. PMID 9849822. (Ipamorelin selectively stimulates GH release; foundational work preclinical, no human muscle-growth proof.)
- Ghigo E, Arvat E, Gianotti L, et al. “Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man.” J Clin Endocrinol Metab. 1994;78(3):693-698. PMID 8126144. (Intravenous hexarelin produced GH release roughly twice that of GHRH, active across multiple routes; no muscle endpoint.)
- Giustina A, Bussi AR, Deghenghi R, et al. “Comparison of the effects of growth hormone-releasing hormone and hexarelin, a novel growth hormone-releasing peptide-6 analog, on growth hormone secretion in humans with or without glucocorticoid excess.” J Endocrinol. 1995;146(2):227-232. PMID 7561633. (The GHRP-6-class peptide produced a larger GH response than GHRH alone in normal subjects; hormone release, not muscle growth.)
- Mendell JR, Sahenk Z, Malik V, et al. “A phase 1/2a follistatin gene therapy trial for becker muscular dystrophy.” Mol Ther. 2015;23(1):192-201. PMID 25322757. (AAV1-FS344 follistatin gene transfer improved 6-minute walk distance in some Becker muscular dystrophy patients; disease population via gene transfer, not healthy adults; no approved follistatin therapy.)
- Knuppel A, Fensom GK, Watts EL, et al. “Circulating Insulin-like Growth Factor-I Concentrations and Risk of 30 Cancers: Prospective Analyses in UK Biobank.” Cancer Res. 2020;80(18):4014-4021. PMID 32709735. (Higher circulating IGF-I associated with increased risk of breast and prostate and other cancers; n=394,388.)
- WADA Prohibited List S2, peptide hormones, growth factors and related substances (lists ibutamoren/MK-677, ipamorelin, hexarelin/GHRPs, IGF-1 and analogues; follistatin-type myostatin inhibition covered under S4.5). (Named growth hormone secretagogues, GHRPs, IGF-1, and myostatin-affecting substances prohibited in sport at all times, irrespective of dose or route.).
